ZA837058B - Peptide and use thereof - Google Patents

Peptide and use thereof

Info

Publication number
ZA837058B
ZA837058B ZA837058A ZA837058A ZA837058B ZA 837058 B ZA837058 B ZA 837058B ZA 837058 A ZA837058 A ZA 837058A ZA 837058 A ZA837058 A ZA 837058A ZA 837058 B ZA837058 B ZA 837058B
Authority
ZA
South Africa
Prior art keywords
peptide
Prior art date
Application number
ZA837058A
Other languages
English (en)
Inventor
Tsukamoto Kyozo
Ichimori Yuzo
Wakimasu Mitsuhiro
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ZA837058B publication Critical patent/ZA837058B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA837058A 1982-09-22 1983-09-22 Peptide and use thereof ZA837058B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1982/000381 WO1984001149A1 (fr) 1982-09-22 1982-09-22 Nouveau polypeptide et son utilisation

Publications (1)

Publication Number Publication Date
ZA837058B true ZA837058B (en) 1984-04-25

Family

ID=13762331

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA837058A ZA837058B (en) 1982-09-22 1983-09-22 Peptide and use thereof

Country Status (3)

Country Link
JP (2) JPS5980646A (enExample)
WO (1) WO1984001149A1 (enExample)
ZA (1) ZA837058B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004420A1 (fr) * 1984-03-29 1985-10-10 Takeda Chemical Industries, Ltd. Nouvel adn et son utilisation
JPH0653067B2 (ja) * 1984-09-11 1994-07-20 武田薬品工業株式会社 新規ハイブリドーマおよびその製造法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation

Also Published As

Publication number Publication date
JPS5980646A (ja) 1984-05-10
WO1984001149A1 (fr) 1984-03-29
JPS6234760B2 (enExample) 1987-07-28
JPS6034994A (ja) 1985-02-22

Similar Documents

Publication Publication Date Title
DE3372705D1 (en) Pharmaceutical composition and its use
EP0097960A3 (en) Bis-crown-ether derivatives and their use
IL68100A0 (en) Novel dna and use thereof
GB8313215D0 (en) Peptides
DE3375143D1 (en) Peptides
PH20572A (en) N-formyl and n-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides
DE3367089D1 (en) 3-phenoxy-1-azetidinecarboxamides and their use and preparation
PH16858A (en) 2-nitroimidazoles and use thereof
GB2124233B (en) Synthetic peptides and their preparation
EP0104144A3 (en) Thermosetting mixtures and their use
GB8327346D0 (en) Peptide
DE3471652D1 (en) Diurethane-diureas and use
GB2130590B (en) Peptides
GB2117757B (en) Alkylspectinomycins and their preparation
GB2126230B (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols preparation and use thereof
ZA837058B (en) Peptide and use thereof
ZA837454B (en) Peptides
JPS57192349A (en) Tripeptide and medicine
GB8302920D0 (en) Peptide and hormone agent
DE3371073D1 (en) Beta-hydroxycyclopentylperoxide compounds and the use thereof
GB2121743B (en) Load-transporting and positioning arrangements
ZA832078B (en) Novel dna and use thereof
DE3463048D1 (en) Furan-3-hydroxamates and their use
DE3367919D1 (en) Furochromones and furobenzopyrans
GB2125290B (en) Clorhexidine and triamcinolon-acetonide preparations